找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Endocrine FGFs and Klothos; Makoto Kuro-o Book 2012 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer S

[復制鏈接]
樓主: FERN
21#
發(fā)表于 2025-3-25 05:16:20 | 只看該作者
Jeffrey M. Bumpous,Mary Worthenors is also different for this sub-family, requiring klotho protein cofactors rather than heparin sulfate proteoglycan. Mouse Fgf15 and human FGF19 play key roles in enterohepatic signaling, regulation of liver bile acid biosynthesis, gallbladder motility and metabolic homeostasis.
22#
發(fā)表于 2025-3-25 11:00:52 | 只看該作者
,Klotho and βKlotho,rs and exert their biological activities. This chapter overviews function of Klotho family proteins as obligate coreceptors for endocrine FGFs and discusses potential link between Klothos and age-related diseases.
23#
發(fā)表于 2025-3-25 12:10:22 | 只看該作者
24#
發(fā)表于 2025-3-25 18:03:53 | 只看該作者
25#
發(fā)表于 2025-3-25 20:05:08 | 只看該作者
26#
發(fā)表于 2025-3-26 00:47:07 | 只看該作者
27#
發(fā)表于 2025-3-26 07:42:13 | 只看該作者
Evidence for FGF23 Involvement in a Bone-Kidney Axis Regulating Bone Mineralization and Systemic Phs through yet-to-be defined locally derived factors. In addition, FGF23 production is regulated by 1,25(OH)2D in a feedback loop where FGF23 stimulate Cyp24 mediated degradation of 1,25(OH)2D that serves to protect the organism from the toxic effects of vitamin D excess. In this chapter, we will review the regulation and function of FGF23.
28#
發(fā)表于 2025-3-26 08:34:54 | 只看該作者
Book 2012 affinity to FGF receptors in their target organs, the endocrine FGFs have designated the Klotho family of transmembrane proteins as obligate co-receptors. By expressing Klothos in a tissue-specific manner, this unique co-receptor system also enables the endocrine FGFs to specify their target organs among many tissues that express FGF receptors.
29#
發(fā)表于 2025-3-26 15:07:12 | 只看該作者
30#
發(fā)表于 2025-3-26 17:51:39 | 只看該作者
https://doi.org/10.1007/978-3-662-33866-7 and lack of apparent side effects in a variety of animal models. Thus, FGF21 represents a novel and appealing therapeutic reagent for Type 2 diabetes mellitus, obesity, dyslipidemia, cardiovascular and fatty liver diseases. The in vitro biology, genetic animal models and in vivo pharmacology of FGF21 will be discussed in this chapter.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-29 09:23
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復 返回頂部 返回列表
阜城县| 达日县| 临城县| 江陵县| 遂平县| 浙江省| 景洪市| 泰和县| 体育| 宁安市| 镇巴县| 马龙县| 莎车县| 长治市| 本溪市| 象山县| 枣庄市| 商丘市| 井研县| 米易县| 胶州市| 南京市| 乌兰察布市| 富平县| 南乐县| 临安市| 望谟县| 新乡市| 资兴市| 辽源市| 周至县| 南靖县| 邯郸市| 上思县| 惠安县| 彝良县| 武川县| 郸城县| 九寨沟县| 宁波市| 明光市|